These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3693759)

  • 1. Home treatment of antibody-deficiency syndromes with intravenous immune globulin.
    Sorensen RU; Kallick MD; Berger M
    J Allergy Clin Immunol; 1987 Dec; 80(6):810-5. PubMed ID: 3693759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home intravenous immunoglobulin therapy by self-administration.
    Ashida ER; Saxon A
    J Clin Immunol; 1986 Jul; 6(4):306-9. PubMed ID: 2427538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis.
    Fu LW; Song C; Isaranuwatchai W; Betschel S
    Ann Allergy Asthma Immunol; 2018 Feb; 120(2):195-199. PubMed ID: 29413344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU; Polmar SH
    Am J Med; 1984 Mar; 76(3A):83-90. PubMed ID: 6424462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home self-administration of intravenous immunoglobulin therapy in children.
    Kobayashi RH; Kobayashi AD; Lee N; Fischer S; Ochs HD
    Pediatrics; 1990 May; 85(5):705-9. PubMed ID: 2109852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.
    Gardulf A; Nicolay U; Math D; Asensio O; Bernatowska E; Böck A; Costa-Carvalho BT; Granert C; Haag S; Hernández D; Kiessling P; Kus J; Matamoros N; Niehues T; Schmidt S; Schulze I; Borte M
    J Allergy Clin Immunol; 2004 Oct; 114(4):936-42. PubMed ID: 15480339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin.
    Wedgewood RJ
    Clin Immunol Immunopathol; 1986 Jul; 40(1):147-50. PubMed ID: 3720023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
    McCormack PL
    BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects and side effects of intravenous gamma globulin I: the problem of immune complex formation].
    Tilz GP; Nydegger U
    Wien Med Wochenschr; 1991; 141(13):301-3. PubMed ID: 1926879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
    Berger M; Murphy E; Riley P; Bergman GE;
    South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin for treating primary immunodeficiency disease.
    Miller DS
    MCN Am J Matern Child Nurs; 1987; 12(4):244-8. PubMed ID: 3112495
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy.
    Gardulf A; Borte M; Ochs HD; Nicolay U;
    Clin Immunol; 2008 Jan; 126(1):81-8. PubMed ID: 17964220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home.
    Ochs HD; Lee ML; Fischer SH; Delson ES; Chang BS; Wedgwood RJ
    J Infect Dis; 1987 Oct; 156(4):652-4. PubMed ID: 3624908
    [No Abstract]   [Full Text] [Related]  

  • 15. I.v. immune globulin: efficacy and safety.
    Minnefor AB; Oleske JM
    Hosp Pract (Off Ed); 1987 Oct; 22(10):171-3, 177-9, 182-3 passim. PubMed ID: 2443521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility of administering Tegeline at home. Retrospective study of efficacy, safety and tolerance].
    Debré M; Clairicia M; Bonnaud F; Jubin O; Thiébaux-Boucard D
    Presse Med; 2004 Jun; 33(10):682-8. PubMed ID: 15257243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.
    Stein MR; Koterba A; Rodden L; Berger M
    Postgrad Med; 2011 Sep; 123(5):186-93. PubMed ID: 21904101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin in primary immunodeficiency.
    Haeney M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):11-5. PubMed ID: 8033427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
    Day NK; Good RA; Wahn V
    Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin therapy for antibody deficiency.
    Nolte MT; Pirofsky B; Gerritz GA; Golding B
    Clin Exp Immunol; 1979 May; 36(2):237-43. PubMed ID: 477026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.